Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04862663
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2021-03-17
Brief Title:
Capivasertib CDK46i Fulvestrant for AdvancedMetastatic HRHER2- Breast Cancer CAPItello-292
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Locally Advanced Inoperable or Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Locally advanced inoperable or Metastatic Breast Cancer | View |